KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Assets: 2019-2025

Historic Return on Assets for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to -0.26%.

  • Moderna's Return on Assets fell 12.00% to -0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.26%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -0.22% for FY2024, which is 1.00% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Return on Assets is -0.26%, which was down 9.87% from -0.23% recorded in Q2 2025.
  • Over the past 5 years, Moderna's Return on Assets peaked at 0.56% during Q1 2022, and registered a low of -0.36% during Q2 2024.
  • In the last 3 years, Moderna's Return on Assets had a median value of -0.24% in 2024 and averaged -0.18%.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 66bps in 2021, then tumbled by 62bps in 2023.
  • Over the past 5 years, Moderna's Return on Assets (Quarterly) stood at 0.54% in 2021, then dropped by 21bps to 0.32% in 2022, then plummeted by 57bps to -0.25% in 2023, then rose by 1bps to -0.24% in 2024, then decreased by 12bps to -0.26% in 2025.
  • Its Return on Assets stands at -0.26% for Q3 2025, versus -0.23% for Q2 2025 and -0.25% for Q1 2025.